Domestic Production Of Mo-99 Gets A Big Boost from the NNSA
The National Nuclear Security Agency, a semiautonomous department of the DOE announced it is awarding North Star Medical Technologies with $37 million in cost-shared funding under two-cooperative agreements. This funding will allow North Star to finish the first phase of its $80 million facility in Beloit, Wis., and expand production at its research reactor in Missouri. The NNSA also provided cost-shared funding to SHINE Medical Technologies, of Janesville, Wis.; Niowave, of Lansing, Mich.; and Northwest Medical Isotopes, based in Corvallis, Ore. All four of these companies are pursuing the production of Mo-99 using a different non-HEU technology. Link:
Are commercial payors denying your SPECT/CT claims? Maybe this will help.
If commercial payors are denying your SPECT/CT reimbursement claims the SNMMI has a medical necessity letter you can personalize to assist with informing the payor about the significant changes in the codes since 2020. Link: SNMMI offers letter to contest SPECT/CT denials (auntminnie.com)